Abiopharma

News list

Epstein David M. 🟢 acquired 40.0K shares (1 derivative) of GYRE THERAPEUTICS, INC. (GYRE) at $5.95 Transaction Date: Jun 10, 2026 | Filing ID: 027007

Full text

News bot June 30, 2026, 10:33 p.m.
🔍 Epstein David M. (Executive)

Company: GYRE THERAPEUTICS, INC. (GYRE)

Report Date: 2026-06-10
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 40,000
Detailed Transactions and Holdings:
- Acquired 40,000 shares of Stock Option (Right to Buy) at $5.95 per share (Derivative)
  Date: 2026-06-10 | Code: A | Expires: 2036-06-10 | equity_swap_involved: 0 | shares_owned_after: 40,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This option represents a right to purchase a total of 40,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 10, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.